Clinical study reports

What is clinical study report (CSR)?

A Clinical Study Report (CSR) is a highly technical document that provides a detailed account of the conduct and outcomes of a clinical trial. These reports play a crucial role in enabling the development and approval of new drugs and medical devices, facilitating future research, and ultimately, improving patient care.

Not all CSRs are the same. Abbreviated CSRs are condensed versions of the full CSR, and may be permitted by regulatory authorities for studies not intended to support the sponsor’s efficacy claim for dose, regimen, population, or indication. Interim CSRs are used to report intermediate results for an on-going study ahead of the primary completion date, while synoptic CSRs typically provide safety data from studies that did not evaluate the product’s effectiveness or clinical pharmacology. Despite these variations, the full CSR is the most comprehensive and standard type of report.

What are the main requirements of a full CSR and how can Alchemy help?

The key requirements for developing comprehensive and informative CSRs include:

1. Adherence to regulatory guidelines
We ensure your CSR adheres to regulatory guidelines outlined by the International Council for Harmonisation (ICH; E3 Structure and Content of Clinical Study Reports), and apply industry best practices to ensure consistency and compliance.

2. Appropriate documentation of study design and methodology
Depending on the client’s preferred template, our writers can prepare a comprehensive overview of the study design, including the objectives, study population, interventions, and data collection methods or, ensure these are covered by appropriate cross-referencing to the Clinical Study Protocol. Either way, we will highlight changes in the planned study conduct and discuss whether these may have any impact on the interpretation of the study.

3. Detailed reporting of study results
We will present your study results in a clear and structured manner, including participant disposition, demographics and baseline characteristics, study drug exposure, efficacy, safety, pharmacokinetics, pharmacodynamics, genetics, biomarkers, immunogenicity and any relevant statistical analyses, as applicable.

4. Comprehensive interpretation and discussion
We can advise on the presentation of data tables and listings, and lead meetings to discuss the interpretation and conclusions of your study findings.

5. Adherence to data privacy and confidentiality
CSRs must protect the privacy and confidentiality of study participants. Our experienced team will ensure your CSR complies with the applicable data privacy regulations and ethical standards.

6. Compilation of Appendices and Publishing
We can advise on preparation of the required CSR appendices, compile them, and publish the entire CSR into a fully cross-linked pdf.

How are CSRs use within the regulatory framework?

CSRs serve as critical documents in the development and approval of new drugs, devices, and therapies. They provide regulators, such as the US Food and Drug Administration, European Medicines Agency, Medicines and Healthcare products Regulatory Agency and Japanese Pharmaceuticals and Medical Devices Agency, with the necessary information to evaluate the safety and efficacy of investigational products, which is a crucial step in the approval process.

Additionally, CSRs are valuable resources for the broader scientific community, as they help facilitate future research, support evidence-based decision-making, and advance medical knowledge and treatment.

What source materials are needed to write a CSR?

To develop comprehensive and high-quality CSRs, we’ll need you to provide us with:

Clinical Study Protocols (CSP) and amendments
Detailed Statistical Analysis Plans (SAP)
Tables, figures, and listing package
MedWatch/CIOMS forms for patient narratives
Any related publications
Other materials for appendices

What is the general timeframe/timeline for writing a CSR?

The development of a CSR is typically a complex and lengthy process, often taking several months to complete. The timeline can vary depending on the size and complexity of the clinical trial, but we can fast-track the development of your CSR if you have a comprehensive internal review team in place. The earlier medical writers get onboard, the faster the CSR can be delivered after database lock.

Overview of the development of a CSR

Diagram showing an overview of the development of a CSR

Alchemy’s top tips and tricks for writing and/or submitting a CSR?

My top tip for CSR writing is breaking down the CSR development process into manageable steps. At Alchemy, we complete the background sections first using source documents like CSP and SAP, which we call ‘creating a shell’. The shell can be created before the final trial data is available, so we are ready to quickly incorporate the results once the study is complete. I strongly believe our structured, phased approach allows us to deliver high-quality CSRs.

Heather Bevan, Senior Medical Writer